Logo image of CMBT

CMB TECH NV (CMBT) Stock Fundamental Analysis

USA - NYSE:CMBT - BE0003816338 - Common Stock

9.63 USD
0 (0%)
Last: 10/17/2025, 8:04:00 PM
9.5079 USD
-0.12 (-1.27%)
After Hours: 10/17/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, CMBT scores 4 out of 10 in our fundamental rating. CMBT was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. While CMBT belongs to the best of the industry regarding profitability, there are concerns on its financial health. While showing a medium growth rate, CMBT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CMBT had positive earnings in the past year.
CMBT had a positive operating cash flow in the past year.
CMBT had positive earnings in 4 of the past 5 years.
Of the past 5 years CMBT 4 years had a positive operating cash flow.
CMBT Yearly Net Income VS EBIT VS OCF VS FCFCMBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

CMBT has a better Return On Assets (4.58%) than 61.14% of its industry peers.
CMBT has a Return On Equity of 29.01%. This is amongst the best in the industry. CMBT outperforms 91.94% of its industry peers.
CMBT has a Return On Invested Capital of 4.07%. This is in the lower half of the industry: CMBT underperforms 62.09% of its industry peers.
CMBT had an Average Return On Invested Capital over the past 3 years of 9.43%. This is significantly below the industry average of 21.53%.
The 3 year average ROIC (9.43%) for CMBT is well above the current ROIC(4.07%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 4.58%
ROE 29.01%
ROIC 4.07%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
CMBT Yearly ROA, ROE, ROICCMBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

Looking at the Profit Margin, with a value of 25.21%, CMBT belongs to the top of the industry, outperforming 81.52% of the companies in the same industry.
CMBT's Profit Margin has improved in the last couple of years.
CMBT's Operating Margin of 25.71% is fine compared to the rest of the industry. CMBT outperforms 63.98% of its industry peers.
CMBT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 54.54%, CMBT is in the better half of the industry, outperforming 62.56% of the companies in the same industry.
CMBT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.71%
PM (TTM) 25.21%
GM 54.54%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBT Yearly Profit, Operating, Gross MarginsCMBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

CMBT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CMBT has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CMBT has been reduced compared to 5 years ago.
CMBT has a worse debt/assets ratio than last year.
CMBT Yearly Shares OutstandingCMBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT Yearly Total Debt VS Total AssetsCMBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.72, we must say that CMBT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.72, CMBT is doing worse than 60.19% of the companies in the same industry.
CMBT has a Debt/Equity ratio of 3.82. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 3.82, CMBT is not doing good in the industry: 87.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.82
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACC0.55
WACC7.34%
CMBT Yearly LT Debt VS Equity VS FCFCMBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 0.82 indicates that CMBT may have some problems paying its short term obligations.
With a Current ratio value of 0.82, CMBT is not doing good in the industry: 65.40% of the companies in the same industry are doing better.
A Quick Ratio of 0.75 indicates that CMBT may have some problems paying its short term obligations.
The Quick ratio of CMBT (0.75) is worse than 63.98% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.75
CMBT Yearly Current Assets VS Current LiabilitesCMBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The earnings per share for CMBT have decreased strongly by -99.67% in the last year.
Measured over the past years, CMBT shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.41% on average per year.
CMBT shows a decrease in Revenue. In the last year, the revenue decreased by -1.96%.
CMBT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.55% yearly.
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
Revenue 1Y (TTM)-1.96%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%53.89%

3.2 Future

CMBT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -23.15% yearly.
Based on estimates for the next years, CMBT will show a very strong growth in Revenue. The Revenue will grow by 32.70% on average per year.
EPS Next Y-88.7%
EPS Next 2Y-31.7%
EPS Next 3Y-23.15%
EPS Next 5YN/A
Revenue Next Year49.05%
Revenue Next 2Y40.36%
Revenue Next 3Y32.7%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CMBT Yearly Revenue VS EstimatesCMBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CMBT Yearly EPS VS EstimatesCMBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

3

4. Valuation

4.1 Price/Earnings Ratio

CMBT is valuated quite expensively with a Price/Earnings ratio of 481.50.
Compared to the rest of the industry, the Price/Earnings ratio of CMBT indicates a slightly more expensive valuation: CMBT is more expensive than 69.67% of the companies listed in the same industry.
CMBT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.40.
The Price/Forward Earnings ratio is 5.58, which indicates a rather cheap valuation of CMBT.
Based on the Price/Forward Earnings ratio, CMBT is valued cheaper than 91.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, CMBT is valued rather cheaply.
Industry RankSector Rank
PE 481.5
Fwd PE 5.58
CMBT Price Earnings VS Forward Price EarningsCMBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

CMBT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CMBT is more expensive than 62.56% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.3
CMBT Per share dataCMBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The decent profitability rating of CMBT may justify a higher PE ratio.
A cheap valuation may be justified as CMBT's earnings are expected to decrease with -23.15% in the coming years.
PEG (NY)N/A
PEG (5Y)11.09
EPS Next 2Y-31.7%
EPS Next 3Y-23.15%

3

5. Dividend

5.1 Amount

CMBT has a yearly dividend return of 0.54%, which is pretty low.
CMBT's Dividend Yield is slightly below the industry average, which is at 6.15.
Compared to an average S&P500 Dividend Yield of 2.38, CMBT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.54%

5.2 History

On average, the dividend of CMBT grows each year by 116.35%, which is quite nice.
CMBT has been paying a dividend for over 5 years, so it has already some track record.
CMBT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)116.35%
Div Incr Years2
Div Non Decr Years3
CMBT Yearly Dividends per shareCMBT Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

59.41% of the earnings are spent on dividend by CMBT. This is a bit on the high side, but may be sustainable.
CMBT's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP59.41%
EPS Next 2Y-31.7%
EPS Next 3Y-23.15%
CMBT Yearly Income VS Free CF VS DividendCMBT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
CMBT Dividend Payout.CMBT Dividend Payout, showing the Payout Ratio.CMBT Dividend Payout.PayoutRetained Earnings

CMB TECH NV

NYSE:CMBT (10/17/2025, 8:04:00 PM)

After market: 9.5079 -0.12 (-1.27%)

9.63

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-13 2025-11-13/bmo
Inst Owners3.04%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.04B
Analysts83.64
Price Target12.1 (25.65%)
Short Float %2.22%
Short Ratio0.99
Dividend
Industry RankSector Rank
Dividend Yield 0.54%
Yearly Dividend5.68
Dividend Growth(5Y)116.35%
DP59.41%
Div Incr Years2
Div Non Decr Years3
Ex-Date10-01 2025-10-01 (0.05)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-173.53%
Min EPS beat(2)-198.04%
Max EPS beat(2)-149.02%
EPS beat(4)0
Avg EPS beat(4)-100.08%
Min EPS beat(4)-198.04%
Max EPS beat(4)-3.67%
EPS beat(8)4
Avg EPS beat(8)61.43%
EPS beat(12)7
Avg EPS beat(12)47.26%
EPS beat(16)10
Avg EPS beat(16)41.59%
Revenue beat(2)1
Avg Revenue beat(2)18.49%
Min Revenue beat(2)-9.81%
Max Revenue beat(2)46.8%
Revenue beat(4)3
Avg Revenue beat(4)13.62%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)46.8%
Revenue beat(8)6
Avg Revenue beat(8)20.12%
Revenue beat(12)10
Avg Revenue beat(12)34.18%
Revenue beat(16)14
Avg Revenue beat(16)38.38%
PT rev (1m)11.37%
PT rev (3m)-10.48%
EPS NQ rev (1m)166.6%
EPS NQ rev (3m)-92.98%
EPS NY rev (1m)-64.19%
EPS NY rev (3m)-63.46%
Revenue NQ rev (1m)11.54%
Revenue NQ rev (3m)36.12%
Revenue NY rev (1m)2.46%
Revenue NY rev (3m)39.1%
Valuation
Industry RankSector Rank
PE 481.5
Fwd PE 5.58
P/S 1.99
P/FCF N/A
P/OCF 11.28
P/B 2.29
P/tB 2.67
EV/EBITDA 13.3
EPS(TTM)0.02
EY0.21%
EPS(NY)1.73
Fwd EY17.92%
FCF(TTM)-3.02
FCFYN/A
OCF(TTM)0.85
OCFY8.86%
SpS4.83
BVpS4.2
TBVpS3.6
PEG (NY)N/A
PEG (5Y)11.09
Profitability
Industry RankSector Rank
ROA 4.58%
ROE 29.01%
ROCE 5.15%
ROIC 4.07%
ROICexc 4.16%
ROICexgc 4.26%
OM 25.71%
PM (TTM) 25.21%
GM 54.54%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
ROICexc(3y)10.41%
ROICexc(5y)N/A
ROICexgc(3y)10.46%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score2
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 3.82
Debt/FCF N/A
Debt/EBITDA 7.9
Cap/Depr 492%
Cap/Sales 80.04%
Interest Coverage 1.85
Cash Conversion 42.05%
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.75
Altman-Z 0.72
F-Score2
WACC7.34%
ROIC/WACC0.55
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
EPS Next Y-88.7%
EPS Next 2Y-31.7%
EPS Next 3Y-23.15%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.96%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%53.89%
Revenue Next Year49.05%
Revenue Next 2Y40.36%
Revenue Next 3Y32.7%
Revenue Next 5YN/A
EBIT growth 1Y-41.59%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year116.95%
EBIT Next 3Y52.74%
EBIT Next 5YN/A
FCF growth 1Y-427.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-54.74%
OCF growth 3YN/A
OCF growth 5Y11.04%